DistantNews
Support us
🇮🇩 Indonesia /Economy & Trade

Phapros Prepares Strategies for Rising Drug Ingredient Costs Amid Dollar Strength

From Republika · () Indonesian

Translated from Indonesian, summarized and contextualized by DistantNews.

At a glance

News Official statement Context piece
  • Indonesian pharmaceutical company PT Phapros Tbk is preparing strategies to manage rising raw material costs.
  • The increase in costs is linked to geopolitical situations and the strengthening US dollar against the Rupiah.
  • The company aims to mitigate the financial impact on its operations and product pricing.

PT Phapros Tbk, an Indonesian pharmaceutical manufacturer, is proactively developing strategies to navigate the increasing costs of raw materials. This financial pressure stems from a combination of global geopolitical tensions and the appreciation of the US dollar relative to the Indonesian Rupiah.

The company's management is exploring various measures to counteract the impact of these economic factors. These strategies are crucial for maintaining operational stability and ensuring the continued availability of essential medicines. Phapros aims to absorb some of the cost increases while minimizing the effect on product affordability for consumers.

Discussions within the company focus on optimizing supply chains, exploring alternative sourcing options, and potentially adjusting pricing structures. The goal is to build resilience against currency fluctuations and global economic uncertainties, safeguarding the company's market position and its commitment to public health.

DistantNews Editorial

Originally published by Republika in Indonesian. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog